§ 13F · FUND PROFILE
Paradigm Biocapital Advisors LP.
AUM · $5.3B (13F)Positions · 28Turnover · n/a · Q2Filed · Aug 14, 2026
CONCENTRATION
n/a
Top 10 holdings
NEW BUYS
0
+$443M deployed
EXITS
0
No exits
SECTOR SHIFT
n/a
No prior quarter data
§ 01 · TOP HOLDINGS
The book · Q2 2026
FILED AUG 14, 2026
| # | Ticker | Name | Shares | $ value | % port | Δ Q2 |
|---|---|---|---|---|---|---|
| 1 | RVMD | REVOLUTION MEDICINES INC | 6.36M | $1.2B | 22.3% | −4% |
| 2 | NUVL | NUVALENT INC | 5.92M | $732M | 13.7% | +11% |
| 3 | EWTX | EDGEWISE THERAPEUTICS INC | 10.22M | $415M | 7.8% | +39% |
| 4 | GMAB | GENMAB A/S | 13.13M | $361M | 6.8% | +65% |
| 5 | SYRE | SPYRE THERAPEUTICS INC | 3.84M | $341M | 6.4% | +96% |
| 6 | APGE | APOGEE THERAPEUTICS INC | 1.58M | $209M | 3.9% | +17% |
| 7 | ORKA | ORUKA THERAPEUTICS INC | 2.14M | $204M | 3.8% | −8% |
| 8 | TNGX | TANGO THERAPEUTICS INC | 6.36M | $199M | 3.7% | +59% |
| 9 | BLTE | BELITE BIO INC | 1.23M | $190M | 3.6% | +11% |
| 10 | ERAS | ERASCA INC | 9.55M | $175M | 3.3% | −8% |
§ 02 · SECTOR ALLOCATION
Where the money is
Sector data pending
§ 03 · THE PARADIGM SIGNAL
AC read
Paradigm Biocapital Advisors LP is a Other fund managing $5.3 billion in assets. The fund runs a focused portfolio of just 28 positions.
Read the full dossier →